Keros Therapeutics, Inc. (KROS) Stock price, Description, News & Info
#Thinksabio latest news Keros Therapeutics Presents Additional Clinical Data from its KER-065 Program at the...
#Thinksabio latest news Keros Therapeutics Presents Additional Clinical Data from its KER-065 Program at the...
#Thinksabio latest news BioAtla Announces Regulatory Update on Clinical Development Plan for Ozuriftamab Vedotin in...
#Thinksabio latest news Enphase Energy Opens U.S. Pre-Orders for IQ9 Commercial Microinverters with GaN, Built...
#Thinksabio latest news Alignment Healthcare Names Matt Eyles Executive Vice President of Government & Business...
#Thinksabio latest news TG Announces Phase 3 Trial for Subcutaneous BRIUMVI Commenced EnrollmentPhase 3 trial...
#Thinksabio latest news Cybin Completes Enrollment in Phase 2 Study Evaluating CYB004 for the Treatment...
#Thinksabio latest news Medicus Pharma Ltd. Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase...
PNC Announces Agreement to Acquire FirstBank, Significantly Growing its Presence in Colorado and Arizona
SEC Filing Update: #UEC : $11.45 Sector: Energy | YTD: 🔼+ 145.71 % The SEC...
SEC Filing Update: #RGEN : $119.89 Sector: Healthcare | YTD: 🔽 -6.67 % The SEC...